Recordati S.p.A: German Approval Received For Zanitek(R), A New Lercanidipine Based Product
Recordati announced that it has received the approval for its new product Zanitek®, a fixed combination of lercanidipine and enalapril, from the BfArM, the German medicines agency. Germany will act as Reference Member State in the mutual recognition approval process for the rest of Europe which is expected to be completed during 2007.